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seven new families and review of the phenotypic
and mutational spectrum of 29 patients
Alireza Haghighi1,2*, Tobias B Haack3,4, Mehnaz Atiq5, Hassan Mottaghi6, Hamidreza Haghighi-Kakhki7,
Rani A Bashir8, Uwe Ahting3,4, René G Feichtinger9, Johannes A Mayr9, Agnès Rötig11, Anne-Sophie Lebre10,
Thomas Klopstock12, Andrea Dworschak13, Nathan Pulido14, Mahmood A Saeed8, Nasrollah Saleh-Gohari15,
Eliska Holzerova3,4, Patrick F Chinnery16, Robert W Taylor17 and Holger Prokisch3,4*Abstract
Background: Sengers syndrome is an autosomal recessive condition characterized by congenital cataract,
hypertrophic cardiomyopathy, skeletal myopathy and lactic acidosis. Mutations in the acylglycerol kinase (AGK) gene
have been recently described as the cause of Sengers syndrome in nine families.
Methods: We investigated the clinical and molecular features of Sengers syndrome in seven new families; five
families with the severe and two with the milder form.
Results: Sequence analysis of AGK revealed compound heterozygous or homozygous predicted loss-of-function
mutations in all affected individuals. A total of eight different disease alleles were identified, of which six were novel,
homozygous c.523_524delAT (p.Ile175Tyrfs*2), c.424-1G > A (splice site), c.409C > T (p.Arg137*) and c.877 + 3G > T
(splice site), and compound heterozygous c.871C > T (p.Gln291*) and c.1035dup (p.Ile346Tyrfs*39). All patients
displayed perinatal or early-onset cardiomyopathy and cataract, clinical features pathognomonic for Sengers
syndrome. Other common findings included blood lactic acidosis and tachydyspnoea while nystagmus, eosinophilia
and cervical meningocele were documented in only either one or two cases. Deficiency of the adenine nucleotide
translocator was found in heart and skeletal muscle biopsies from two patients associated with respiratory chain
complex I deficiency. In contrast to previous findings, mitochondrial DNA content was normal in both tissues.
Conclusion: We compare our findings to those in 21 previously reported AGK mutation-positive Sengers patients,
confirming that Sengers syndrome is a clinically recognisable disorder of mitochondrial energy metabolism.
Keywords: Sengers syndrome, AGK, Acylglycerol Kinase, Mutation, Genotype-Phenotype CorrelationIntroduction
Sengers syndrome is a rare autosomal recessive con-
dition. It was first described by Sengers and colleagues
in 1975 with the clinical features of congenital cataract,
hypertrophic cardiomyopathy, mitochondrial myopathy
and lactic acidosis after exercise [1].* Correspondence: haghighi@genetics.med.harvard.edu; prokisch@helmholtz-
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unless otherwise stated.Two forms of this syndrome have been described, a se-
vere neonatal form that causes infantile death and a
more benign form with a longer survival into the fourth
decade [2,3]. The longer surviving patients had normal
developmental milestones. The cause of mortality in
Sengers syndrome is heart failure as the result of hyper-
trophic cardiomyopathy. Van Ekeren et al. investigated
16 clinically-diagnosed patients with Sengers syndrome
in order to describe the course of these two forms [2,3].
Although these authors did not observe any histopatho-
logic distinction in muscle or heart samples between the
two forms, Perry described 3 cases of neonatal Sengers
with significant central nervous system involvement [4].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lings included cerebellar hypoplasia and increased echo-
genicity of the basal ganglia suggestive of calcification.
Magnetic resonance imaging demonstrated hypoplasia
of both the brainstem and inferior cerebellar vermis,
impaired myelination of the cerebral hemispheres and
brainstem, and cortical infarction [5]. These authors sug-
gested that the neonatal form of Sengers syndrome
should be described as a mitochondrial encephalomyo-
pathy, because of involvement of the central nervous
system. However, the genetic cause of the disease in this
family has not been reported. Siriwardena et al. investi-
gated two siblings with Sengers Syndrome and AGK mu-
tations using magnetic resonance imaging and showed
cortical infarction, however in a vascular pattern unlike
metabolic strokes that do not respect any arterial distri-
bution [6].
Recently, Mayr et al. investigated Caucasian Sengers
patients from Germany, Italy, The Netherlands and
Switzerland and, using whole exome sequencing, identi-
fied AGK as the disease-causing gene in Sengers syndrome
[4]. AGK encodes a mitochondrial transmembrane en-
zyme, acylglycerol kinase, a multisubstrate lipid with a
likely role in cardiolipin biosynthesis. Acylglycerol kinase
catalyzes the formation of phosphatidic acid and lysopho-
sphatidic acid [7] that can participate in phospholipid syn-
thesis or act as signaling molecules regulating a number of
cell processes [7–9]. Cardiolipin plays an important role
in structural maintenance of mitochondria and regulating
the permeability of the inner membrane. Abnormal mito-
chondrial morphology has been seen in conditions with
cardiolipin impairment, like Sengers and Barth syndromes
[10–12]. Secondary to AGK mutations, a deficiency of the
adenine nucleotide translocator and impairment of ATP
synthesis has been reported and seems to play a central
role in the pathomechanism of Sengers syndrome [4,13].
We present the clinical features and molecular basis of
Sengers syndrome in seven new families of different eth-
nic origin, documenting for the first time a molecular
study of Sengers syndrome patients of non-Caucasian
descent.Materials and methods
Patients and families
We studied the members of seven families with Sengers
syndrome in which patients were diagnosed based on
the clinical features and mitochondrial histochemical
and biochemical analysis. Informed written consent for
clinical and molecular investigation was obtained from
all family members or their legal guardians. The study
was conducted in accordance with the Helsinki Decla-
ration. The study was approved by the ethics committee
of the Technische Universität München.All members of families underwent a comprehensive
clinical investigation including cardiac, metabolic, neu-
rological, endocrinological, ophthalmological and neuro-
muscular assessments.
Methods
Peripheral blood samples were collected from all family
members.
The causal mutation in Case 4 (Table 1) was identified
by exome sequencing as described previously [14] and
subsequently confirmed by Sanger sequencing. In the
other individuals, testing for DNA sequence variations in
AGK was done by Sanger sequencing. Genomic DNA was
amplified using intronic primers and the resulting PCR
products were sequenced in both directions. Primer se-
quences and PCR conditions are available upon request.
The mtDNA content from 3 patient samples was mea-
sured in muscle or heart from three patients with samples
available for testing according to published protocol [15].
Western blot analysis was performed from very small
amount of tissue samples from 2 patients, therefore only
ANT and respiratory chain complexes I and II were
determined as described in [4]. Biochemical analysis of
OXPHOS activity was done in 3 different research centers,
where the muscle biopsies were available (case-4, 5, 7 [4]).
Results
Clinical investigation
Altogether, we report 8 new cases of Sengers syndrome
with predicted loss-of-function mutations in all affected
individuals with no hot-spot region in AGK gene. Six pa-
tients displayed onset of cataract at birth, one in the first
month of life. Cardiomyopathy occurred at birth in 5
out of 8 cases and in two cases within the first 5 months
of life. For one case, the onset of cardiomyopathy
remained unclear. Five patients with severe form or
Sengers syndrome died in the first year of life, last pa-
tient with severe form is alive with the age of 3 moths.
Patients with milder form of disease survived the first
decade of their life. Our data underline tachydyspnea
and isolated Complex I deficiency as additional phe-
notypes of Sengers syndrome. Consistently to previous
findings, blood lactic acidosis was found as a common
feature for all cases with severe form of disease, most
with respiratory chain deficiency. Other features like
nystagmus, eosinophilia, cervical meningocele, exercise
intolerance or motor developmental delay and muscle
weakness differ case by case. Specific information are
given in the case reports or in the overview Table 1.
Family-1
The first proband (Case-1, Table 1) was a five months
old male child that presented with coughing and respira-
tory difficulties for one week, reluctance to feed and
Table 1 Molecular and Clinical Findings in Patients with AGK Mutations
FEATURES Sex/consan. Mutation Status
Onset of
cardio-
myopathy
Onset of
cataract
Plasma
lactic
acidosis
Exercise
intolerance
Motor
develop.
delay
Muscle
weak.
Muscular
hypotonia
Tachydys-
pnea
OXPHOS
defect
Other clinical
features
Case-1 Male/+
c.523_524delAT
(p.Ile175Tyrfs*2)¥
Dead 7 m 5 m 1 m +
Feeding
difficulty
+ + + +
Nystagmus, floppy
infant
Case-2A
Male/
- (Fm)
c.424-1G>A
(splicing defect)¥
Dead 10 d Birth Birth + - - - - + -
Case-3A
Female/
- (Fm)
c.424-1G>A
(splicing defect)¥
Dead 4 m Birth Birth +
Feeding
difficulty
- - - - Eosinophilia
Case-4
Female/
- (Fm)
c.409C>T
(p.Arg137*)¥
Dead 3 m + + + I
Esotropia, IUR, feeding
problems, MMA
elevation in urines
(14 , N>8), total and
free carnitine
elevation in blood,
fatty infiltrations in
heart biopsy
Case-5 Male/-
c.409C>T
(p.Arg137*)¥
Dead 6 m Birth Birth +
Feeding
difficulty
+ + + + I
Esotropia, nystagmus,
floppy infant
Case-6
Male/
- (Fm)
c.871C>T
(p.Gln291*),
c.1035dup
(p.Ile346Tyrfs*39)
Alive 3 m Birth Birth + -
Mild
retardation
Mild Mild
+ RSV
pneumonia
-
Case-7 Female/-
c.297+2T>C
(p.Lys75Glnfs*12),
c.841C>T
(p.Arg281*)
Alive 10 y Birth Birth - + + + + - I
Cervical meningocele,
ragged red fibers
(15%), COX-deficient
fibres (1-2%)
Case-8 Male/+
c.877+3G>T
(splicing defect)¥
Alive 15 y + Birth - + + - - -
PC-1 [4] Male/-
c.3G>C (p.Met1?),
c.517C>T
(p.Gln173*)
Alive 36 y + 3 m + + + - - - Floppy infant
PC-2 [4]
Male/
- (Fm)
c.3G>C
(p.Met1?),
c.672C>A
(p.Tyr224*)
Alive 35 y + 3 m
On
exercise
+ + - - - - -
PC-3B [4]
Male/
- (Fm)
c.1131+5G>A
(splicing defect)¥
Dead 12 y + 18 m - + - + + -
I, II+III, IV,
V, PDHc
-
H
aghighiet
al.O
rphanet
Journalof
Rare
D
iseases
2014,9:119
Page
3
of
12
http://w
w
w
.ojrd.com
/content/9/1/119
Table 1 Molecular and Clinical Findings in Patients with AGK Mutations (Continued)
PC-4B [4]
Female/
- (Fm)
c.1131+5G>A
(splicing defect)¥
Alive 10 y + 5 m + + - - - -
I, II+III, IV,
V, PDHc
-
PC-5 [4] Female/+
c.1131+5G>A
(splicing defect)¥
Alive 41 y + Birth + + - - - V Stroke
PC-6 [4] Female/-
c.221+1G>A
(splicing defect),
c.1213C>T
(p.Gln405*)
Alive 12 y + Birth + - - + - -
I, II, III, IV,
very high CS
-
PC-7 [4]
Male/-
(Fm)
c.412C>T
(p.Arg138*),
c.1137_1143del
(p.Gly380Leufs*16)
Dead
11 m
+ Birth
On
exercise
-
Moderate
retardation
- + - -
Fatty infiltrations in
muscle biopsy
PC-8 [4] Female/-
c.672C>A
(p.Tyr224*),
c.870del
(p.Gln291Argfs*8)
Dead
10 m
+ 4 m + - - - - -
I, II, III, IV, V,
very high CS
-
PC-9 [4] Male/-
c.101+?_222-?del
(ND)¥
Dead 8 m + Birth + - - - - -
I, II, III, IV, V,
very high CS
Axial hypotonia,
upper left limbs
paresis, seizures, brain
ventricles dilation
PC-10 [4] Male/-
c.306C>T
(p.Tyr102*),
c.841C>T (p.Arg281*)
Dead 18 d + Birth + - - - - + I, II+III, IV, V -
PC-11 [16] Female/-
c.297+2T>C
(p.Lys75Glnfs*12),
c.1170T>A
(p.Tyr390*)
Dead 18 y + <1 year + + I, III, IV
Fatigue, failure to
thrive, recurrent
headaches,
osteopenia and
premature ovarian
failure, severe mtDNA
depletion in skeletal
muscle
PC-12 [16] Female/+
c.1131+1G>T
(p.Ser350Glufs*19)¥
Dead 4 d Birth + + + I, III, IV
Pulmonary
hypertension, marked
respiratorydistress,
thrombocytopenia,
severe mtDNA
depletion in skeletal
muscle
PC-13 [6] Female/+
c.979A>T
(p.Lys327*)¥
Dead 5 m Birth Birth +
Upper respiratory
tract infection
PC-14 [6] Female/+
c.979A>T
(p.Lys327*)¥
Dead 12 d Birth Birth +
I, I+III, II+III, III,
IV, high CS
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Table 1 Molecular and Clinical Findings in Patients with AGK Mutations (Continued)
PC-15 [6] Male/+
c.979A>T
(p.Lys327*)¥
Dead 2 d Birth Birth
PC-16 [6] Male/+
c.979A>T
(p.Lys327*)¥
Dead 18 d Birth Birth
PC-17 [6] Male/+ c.3G>A (p.Met1?)¥ Dead 6 m Birth Birth + + +
Cerebellar non-
hemorrhagic stroke,
ventricular , growth
delayfibrillation
PC-18 [6] Male/+ c.3G>A (p.Met1?)¥ Alive 2 y 2 m Birth - - - -
Cerebellar non-
hemorrhagic stroke,
ventricular, modest
growth
delayfibrillation
PC-19 [18] Female/+
c.424-3C>G
(p.Ala142Thrfs*4)¥
Alive 17 y - Birth - - - - - -
Urine organic acid
profile: moderately
elevated lactate,
3-hydroxyisovaleric,
3-methylglutaric and
3-methylglutaconic
acids
PC-20 [18] Male/+
c.424-3C>G (p.
Ala142Thrfs*4)¥
Alive 11 y - Birth - - - - - -
Urine organic acid
profile showed
moderately
elevated lactate,
3-hydroxyisovaleric,
3-methylglutaric and
3-methylglutaconic
acids
PC-21 [18] Male/+
c.424-3C>G (p.
Ala142Thrfs*4)¥
Alive 7 y - Birth - - - - - -
Urine organic acid
profile showed
moderately elevated
lactate, 3-
hydroxyisovaleric,
3-methylglutaric and
3-methylglutaconic
acids
SUMMARY 17 M: 12 F/13 consan.
20 homozygous; 19
different mutations
17 †;
16 † <1 y
25/29; 10
at birth
28/29 up
to 18 m;
21 at birth
20/27
6/16; + 3
feeding
difficulties
10/22 8/23 7/22 7/22
3 only I;
1 only V;
9 combined
+: presence of condition, −: absence of condition, unknown when empty.
I: complex I, II+III: succinate cytochrome c oxidoreductase, IV: cytochrome c oxidase, V: oligomycin-sensitive ATPase, CS: citrate synthase, OXPHOS: oxidative phosphorylation, PDHc: pyruvate dehydrogenase complex;
Fm: familial, ND: not determined;
d: day, m: month, y: year;
ACases 2 and 3 are siblings;
BPC-3 and PC-4 are siblings;
¥Homozygous mutation.
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http://www.ojrd.com/content/9/1/119excessive crying for a few hours. There was no associated
fever, vomiting or history of drug intake. He was the first
born at term to healthy consanguineous parents from
Pakistan. At birth, the child was diagnosed with bilateral
cataract. Rubella and galactosemia were ruled out. He
underwent cataract surgery uneventfully during the first
month of life. He had subsequent admissions for eye
examinations under anesthesia and circumcision; both
admissions were without complications. The child was
noticed to sweat and get tired during feeding. His physical
growth was normal. Motor milestones were delayed and
the child was unable to hold his neck. Family history was
significant with neonatal deaths in two paternal uncles.
On admission, he had supraventricular tachycardia with a
heart rate of 230 bpm with congestive cardiac failure. The
respiratory rate was 46/m with acidotic breathing pattern
and blood pressure was 80/60 mmHg. The heart sounds
were distant and there was no murmur. He had moderate
hepatomegaly. His eyes were aphakic, pupils being irregu-
lar shaped, sluggishly reactive to light. He also had gener-
alized hypotonia. Electrocardiogram was consistent with
supraventricular tachycardia. This was aborted with car-
dioversion and a repeat electrocardiogram showed left
ventricular hypertrophy and T wave inversion in limb and
chest leads (Figure 1a). Arterial blood gases depicted
severe metabolic acidosis (pH 6.9, pCO2 32.6 mmHg,
pO2 98 mmHg, HCO3 6 meq/L) and anion gap was
29 meq/L. Serum lactate level was 20 mmol/L (normal
0.67-2.67 mmol/L). Echocardiography was consistent with
hypertrophic non-obstructive cardiomyopathy (Figure 1b)
with a severe global systolic dysfunction (ejection fraction
15%). Moderate mitral and tricuspid valve regurgitation
were present. The child was suspected to have Sengers
syndrome. A skeletal muscle biopsy taken from gastrocne-
mius muscle was stained with routine stains and examined
under light microscopy. Abnormal muscle fibers were
found with histiocytic infiltrates. Special stains did not
show ragged red fibers nor storage cells. Cytochrome
c oxidase histochemistry and electron microscopy were
not available to study abnormal mitochondria.
Family-2
The second proband (Case-2, Table 1) was a full term
baby boy born to a 29 year old gravida-2 mother by vac-
uum extraction for fetal decelerations. His birth weight
was 3.28 kg. Apgar score was 5, 8, 8 at 1, 5, 10 minutes,
respectively. There was cord round the neck tight and
oligohydramnios. He responded well to resuscitation.
The antibodies for toxoplasmosis were negative. A pre-
vious sibling (Case-3, Table 1) was a term girl with bilat-
eral congenital cataract and congenital heart disease.
Her echo showed fenestrated atrial septal defect (ASD)
and interventricular septal hypertrophy. Anticongestive
medications were started for the neonate but she died atthe age of 4 months. There was an episode of high lac-
tate while the girl was in the neonatal intensive care
unit, associated with diarrhea which self-recovered. Pa-
rents were non consanguineous, but they hailed from
the same village in India. At birth, the baby was noted
to be hypoperfused, tachypneic and with grade 3/6 pan-
systolic murmur over the left sternal edge. Initial blood
gas showed a mild metabolic acidosis, which normalized
after a normal saline bolus. Chest X-ray showed gross
cardiomegaly (Figure 1c). Ophthalmology consultation
revealed bilateral lamellar cataract. Echocardiography
(Figure 2) at 48 hours of life revealed moderate secun-
dum ASD (5 mm), pulmonary arterial pressure 80% at
the systemic level, moderate right ventricular hyper-
trophy and right atrial dilatation. The ejection fraction
was 54%. As per the advice of the cardiologist, he was
started on oral sildenafil, furosemide and dopamine.
The tachypnea gradually improved and finally he could
be maintained on full feeds. Ultrasound evaluation of
brain and abdomen were normal. Repeat echocardio-
graphy after 72 hours showed hypertrophic left ventricle
with ejection fraction 50% and improvement of pulmon-
ary hypertension. Maintenance digoxin was started
along with increasing doses of captopril. Sildenafil and
dopamine were stopped and furosemide and spironolac-
tone were continued. Basic metabolic work-up showed
serum lactate of 14.5 mmol/L, which on repeat was
6 mmol/L and ammonia and blood gas levels were
normal. At the age of 10 days, he was irritable, pale and
desaturating. He became bradycardic. Blood gas tests
showed severe metabolic acidosis and chest X-ray re-
vealed increasing cardiomegaly. Despite the resuscita-
tive efforts, baby expired.
Family-3
The proband (Case-4, Table 1) was a girl, the second
child from healthy non consanguineous Indian parents.
They previously lost a first child at 3 days of life pro-
bably due to infection. She was born after an uneventful
pregnancy. Bilateral cataract was noticed at birth. When
she was 2.5 months old, her severe hypertrophic cardio-
myopathy was detected after she collapsed during cata-
ract surgery. The girl had growth retardation (weight
3.770 g/-1.5SD, head circumference 36 cm/-1.5SD),
strabismus and feeding difficulties. She presented hy-
perlactatemia and hyperlactaturia. Plasma glutamine,
alanine, proline, and free and total carnitine levels
were elevated. Methylmalonic acid was raised in urine
(14 μmol/mmol creatinine, normal < 8 μmol/mmol). An
isolated complex I deficiency was found in endomyocar-
dial biopsy, whereas cultured skin fibroblasts showed
normal respiratory chain activities. A heart biopsy re-
vealed fatty infiltrations. She died at the age of 3 months
from heart failure.
Figure 1 Electrocardiogram, echocardiogram and chest X-ray of a Sengers patient. a. ECG of Case-1 showing left ventricular hypertrophy
and T wave inversion in limb and chest leads. b. 2D echocardiogram of in parasternal long axis projection showing severe left ventricular
hypertrophy in (Case-1). c. Chest X-ray revealing significant cardiomegaly in (Case-3).
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The male patient (Case-5, Table 1) was born at term by va-
ginal delivery. The newborn was initially in a good condi-
tion with a normal Apgar score of 9-10-10. Later on, he
started to present symptoms of heart failure with tachypnea
and hepatomegaly. Echocardiography showed profound
concentric hypertrophy of the left ventricle. The cavum of
the left ventricle was almost completely obstructed but
left ventricular outflow tract was well developed and un-
obstructed. Anticongestive treatment with diuretics was
started, but did not improve the condition. He also deve-
loped lactic acidosis. Physical examination showed muscular
hypotonia and dystrophic features. Ophthalmologic exa-
mination showed bilateral cataract that was operated later
on. Muscle biopsy excluded Pompe disease, but showed low
activity of mitochondrial respiratory chain complex I. In the
further course, the child developed a mild form of necro-
tizing enterocolitis with intestinal bleeding and air collection
in the portal vein. Antibiotic therapy was started while he
was kept on parenteral nutrition for a couple of days that
made him clinically more stable. Furthermore, he was
placed on ketogenic diet, riboflavin (40 mg/d) and coen-
zyme Q 10 (40 mg/d). In addition, propranolol was started
because of heart failure. At the age of two months, the in-
fant was discharged from hospital on parents’ request. He
passed away three months later, at the age of five months.Family-5
The proband (Case-6, Table 1) was a 3 months boy infant,
from Chile, who was admitted because of respiratory syn-
cytial virus (RSV) bronchiolitis and pneumonia. He was
born to healthy non-consanguineous parents. On chest
radiography, his heart was enlarged. He was diagnosed
with bilateral cataract since birth too. Echocardiography
revealed non-obstructive hypertrophic cardiomyopathy
with poor left ventricular function. His older brother died
at the age of 15 months due to severe heart failure and
cardiogenic shock. He also had hypertrophic cardiomyop-
athy, bilateral cataract and lactic acidosis. Autopsy path-
ology showed cytosolic granules in heart muscle and liver
cells. He also had neurological developmental delay and
mild hypotonia. Severe viral respiratory infection was re-
ported in this patient as well.
Family-6
The patient (Case-7, Table 1) was a 10 year old girl, born
to non-consanguineous healthy parents. The pregnancy
was complicated by early bleeding. The heart abnormality
was detected at the 19 week ultrasound scan. She was
born by vaginal delivery and required minimal resuscita-
tion. On physical exam at birth, the absence of a red reflex
led to diagnosis of cataract that was operated in infancy.
As an infant she was also diagnosed with a cervical
Figure 2 Echocardiography of a Sengers patient. a. M-Mode of LV in short axis showing dilated LV for age of (Case-3) at 6 days (LVEDD 2.04).
b. moderate mitral valve regurgitation with left atrial contraction in systole. c. moderate tricuspid regurgitation with right atrial contraction
envelope in systole.
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eration within 6 months of life. Echocardiography at the
7 days of age, revealed a hypertensive hypertrophic cardio-
myopathy. She walked at 18 months of age and had sig-
nificant speech and language delay with only minimal
vocalization at the age of 2 years. On physical examination
at 2 years of age, all growth milestones (height, weight and
head circumference) were below 4th centile, she had poor
muscle mass and hypotonia but no overt dysmorphic fea-
tures. She had normal cognitive functions and later went
to normal school. She had growth hormone deficiency
that was treated by growth hormone. The abnormal cli-
nical findings at the last visit, at the age of 10 years, in-
cluded exercise intolerance, fatigue, hypotonia, and stable
cardiomyopathy. Muscle biopsy revealed an isolated com-
plex I deficiency in muscle.
Family-7
The proband (Case-8, Table 1) was a 15 year old boy,
the second child of healthy consanguineous parents.
Growth retardation, cataract, muscular hypotonia andmoderate motor retardation were noted in infancy by
the parents. Rubella and galactosemia were ruled out.
On physical examination, at 2 years of age, he had bis-
feriens carotid pulse, grade 2–3/6 systolic murmur, nor-
mal S1 and single S2. Echocardiography revealed left
and right ventricular outflow tract obstructions, signifi-
cantly increased left ventricular mass index, biventricular
diastolic dysfunction and mitral valve regurgitation. Car-
nitine therapy was initiated for the patient but no clin-
ical improvement was observed. His younger brother
had also had cataract, cardiomyopathy and metabolic
disorder and died at the age of 3 months.
AGK mutation analysis
Sequencing analysis of AGK identified disease-causing
mutation in all patients. Molecular analysis of the gen-
omic DNA from Family-1 identified a novel homozygous
2 bp deletion (c.523_524delAT) mutation in the pro-
band, predicting a frameshift (p.Ile175Tyrfs*2) in the
translated protein. Both parents were confirmed to be
heterozygous carriers.
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vealed a novel homozygous canonical splice site muta-
tion c.424-1G > A in the proband, affecting exon 8. Both
parents and a healthy sibling were heterozygous for this
mutation.
Molecular study in families 3 and 4 detected a homo-
zygous nonsense mutation, c.409C > T, predicting a pre-
mature termination codon at position 137 of AGK,
p.Arg137*. The parents, in both families, were heterozy-
gous for this mutation.
Genetic study of Family-5 identified novel loss-of-
function compound heterozygous mutations, a nonsense
variant c.871C > T, (p.Gln291*), in exon 12, and a one-
nucleotide insertion c.1035dup in exon 14 that is pre-
dicted to result in a frameshift (p.Ile346Tyrfs*39). The
healthy parents were heterozygous for either of these
two mutations.
Sequencing of the proband in Family-6, identified a
heterozygous nonsense mutation c.841C > T (p.Arg281*)
in combination with a heterozygous canonical splice site
mutation c.297 + 2 T > C that has been shown to cause
a shortened transcript with a premature termination
codon (p.Lys75Glnfs*12) [16].
Molecular analysis of Family-7 revealed a homozygous
mutation (c.877 + 3G > T) that is likely to affect splicing
of exon 12.
The results of genetic analysis are summarized in
Table 1. Figure 3 illustrates the localization of identified
mutations in the AGK gene.
Immunoblotting
Western blot analysis was performed with the muscle
biopsy sample of the patient from Family-4 and a heart
biopsy sample of a previously published patient (PC-8,
Table 1), diagnosed with combined respiratory chain
deficiency [4]. Antibodies against the adenine nucleotide
translocator revealed a clear decrease in both the heart
and the muscle sample (Figure 4). Complex I was mo-
derately decreased in muscle but severely decreased in
the heart sample (Figure 4).Figure 3 Gene structure of AGK and localization of identified mutatioQuantification of the mitochondrial DNA copy number
The relative mitochondrial DNA content in the muscle
biopsy of the patient from families 4 and 6 and the heart
sample of the previously published patient PC-8 was an-
alyzed by quantitative real time PCR (qRT-PCR) [15]. A
high normal value of 1750 ± 390 copies of mitochondrial
DNA (mtDNA) per nuclear genome (normal range 750-
1610) was found in the muscle samples from case 5 and
levels within the normal range for case 7 (130% of the
mean from controls). The relative mtDNA content in
the heart sample was 4240 ± 730 copies of mtDNA per
nuclear genome which is within a range of two controls
(1042 and 5131).
Discussion
Sengers syndrome is caused by mutations in the AGK gene
[4], which is located on chromosome 7q34 and consists of
16 exons. To date, only three studies have investigated
families with Sengers syndrome and identified different
types of loss-of-function mutations in AGK gene, including
start codon mutations (compound heterozygous), non-
sense (compound heterozygous), frameshift (compound
heterozygous) and splice site mutations (homozygous and
compound heterozygous) [4,16]. An overview about the
clinical, biochemical and genetic findings of all published
and recently identified patients is summarized in Table 1.
We investigated the clinical features and molecular basis
of Sengers syndrome in seven new affected families. We
have identified six novel predicted loss-of-function muta-
tions in AGK; homozygous c.523_524delAT (p.Ile175-
Tyrfs*2), c.424-1G >A (splice site), c.409C > T (p.Arg137*)
and c.877 + 3G > T (splice site), and compound hetero-
zygous c.871C > T (p.Gln291*) and c.1035dup (p.Ile346-
Tyrfs*39). Figure 3 provides an overview of the known and
newly identified mutations.
To date, less than 10 families with neonatal Sengers
syndrome have been reported [4,5]. The average survival
of the severe form (with onset in the first month of life),
in our and previously published cases, was 4.2 months,
whereas Mayr et al. reported patients with the milderns. Boldface type indicates newly reported mutations.
Figure 4 Western blot analysis of heart and muscle samples.
The blots were decorated with antibodies (all from Mitosciences/
Abcam (Eugene, OR, USA)) against adenine nucleotide translocator
(ANT), subunit NDUFS4 of complex I, and subunit SDHA of complex II.
Intensities were quantified by the Image J software (National Institutes
of Health, Bethesda, MD) and relative intensities were calculated for the
patient sample in each tissue in relation to the two controls. P1stands
for PC-8 and P2 stands for Case 5 in the Table 1.
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decade of life (cases PC-5, PC-1 and PC-2, Table 1). Very
early mortality (<5 days of life) has also been reported
(cases PC-12 and PC-15, Table 1). Calvo et al. described
truncating AGK mutations in two patients with bilateral
cataract, severe myopathy and combined complex I, III
and IV deficiency [16]. The first patient (PC-11, Table 1)
was born to unrelated parents and harbored compound
heterozygous mutations; a splice site mutation c.297 +
2 T > C (p.Lys75Glnfs*12) resulting in a shortened
transcript, and a nonsense mutation c.1170 T > A
(p.Tyr390*). Her other clinical features included failure to
thrive, fatigue, recurrent headaches, osteopenia and pre-
mature ovarian failure. She died at the age of 18 months.
The second patient (PC-12, Table 1), born to a con-
sanguineous family, was homozygous for a splice site mu-
tation, c.1131 + 1G > T (p.Ser350Glufs*19), that causes a
shortened transcript. The infant had severe lactic acidosis
(10 –17 mmol/L, normal 0.7–2.0) (John Christodoulou,
personal communication) and metabolic acidosis, and died
at 4 days of age due to cardiorespiratory collapse [16].
Tachydyspnoea was a feature which was observed only
in severe from of the disease (Table 1), and not in any of
patients with the milder form. This feature seems to be
correlated with poorer prognosis and survival (average ~
2.8 months).
The unusual features in our patients were nystagmus
(Case-1 and Case-5), eosinophilia (Case-3) and cervical
meningocele (Case-7). In addition, esotropia was found
in two patients (Case-4 and Case-5) with the c.409C > T
(p.Arg137*) mutation.We did not identify a hot-spot region within the AGK
gene showing clustering of mutations; these were equally
distributed over the whole gene sequence. So far, all AGK
mutations associated with Sengers syndrome are predicted
to be loss-of-function variants. However, we noted that
homozygous AGK nonsense mutations have always re-
sulted in infantile (severe) form of the Sengers syndrome
while all patients who survived the first decade harbor at
least one splice site variant or a start codon mutation. In
fact, two out of the three oldest patients with survival
of >35 years carry the c.3G > C (p.Met1?) mutation in
combination with two different stop codon mutations and
the third one was homozygous for the splice mutation
c.1131 + 5G >A, frequently found in patients from The
Netherlands. This observation may indicate some AGK
activity through residual normal splicing or alternative
start codon usage[17].
Very recently, Aldahmesh et al. identified a splice site
mutation in AGK causing isolated congenital cataract (re-
cessive cataract 38) in a multiplex consanguineous family
from Saudi Arabia, thereby extending the mild clinical
spectrum associated with AGK mutations to a non-
syndromic form. Urine organic acid profile showed mode-
rately elevated lactate, 3-hydroxyisovaleric, 3-methylglutaric
and 3-methylglutaconic acids (Fowzan Alkuraya, personal
communication) and interestingly, cardiology evaluation
of the affected family members revealed normal results
(Table 1). The identified mutation, c.424-3C >G, is pre-
dicted to lead to aberrant splicing and predicted prema-
ture truncation, p.Ala142Thrfs*4 [18]. It can be speculated
therefore that a small proportion of the normally spliced
transcript can still be formed.
Although the role of AGK mutations in cataractogen-
esis is unclear, some authors have raised the hypothesis
that an impairment of lenticular lipid composition may
be of pathophysiological significance in the etiology
[18,19]. In our and previously published cases with the
severe form of Sengers syndrome, cataract was present
at birth or detected shortly thereafter, whereas in milder
form, it can remain undiagnosed for several months
(18 months of age in PC-3, Table 1).
Several patients (Case-7, Case-8, PC-3 and PC-18,
Table 1) with a milder form of Sengers syndrome did not
develop lactic acidosis, whereas in the severe form, none
of the patients had normal levels of lactic acid. Siriwardena
et al. reported a Sengers patient with the start codon mu-
tation, p.Met1?, who interestingly, at the age of 3 years, did
not have skeletal myopathy. He was able to run and play
without any limitation and his creatine phosphokinase
levels were also normal. His skeletal muscles biopsy, at the
age of 4 months, did not show presence of COX negative
fibers [6]. However, his sibling, obviously with the same
AGK mutation, was affected with the severe form of
the diseases and died at the age of 6 months. These
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ent from lactic acidosis and that the absence of lactic acid-
osis favors a better prognosis with longer-term survival,
even in patients with the same AGK mutations. This ob-
servation resembles patients with Barth syndrome, which
is known to show clinical variability found in siblings with
identical TAZ genotype [20]. Remarkably, these two mito-
chondrial disorders also seem to result in a decrease of
complex I, which has been demonstrated by western blot
analysis in Barth syndrome [21] and shown here in a heart
and to milder extent a skeletal muscle sample (Figure 4).
Based on the finding of severe mtDNA depletion in
skeletal muscle in two patients reported by Calvo and
colleagues [16], Sengers syndrome is now also called car-
diomyopathic mitochondrial DNA depletion syndrome-
10 (OMIM 212350). In contrast to this published study,
we did not find any indication for mtDNA depletion in
muscle or heart from three patients with samples avail-
able for testing. Moreover, in the original publication of
the clinical syndrome by Sengers and colleagues [1], the
biochemical analysis of mitochondrial enzyme complex
activities revealed normal results, which is incompatible
with a severe loss of mtDNA copy number [1,6]. To
date, only nine patients with AGK mutations have been
reported to have a combined respiratory chain deficiency
indicating that mtDNA depletion is not a common fea-
ture of Sengers syndrome.
Based on our findings, we can describe two distinct
forms of Sengers syndrome, an infantile or severe form
and a mild form. The infantile form of Sengers syn-
drome is caused by homozygous AGK nonsense muta-
tions and is characterized by early onset (within the first
few months of life) cardiomyopathy and lactic acidosis
that causes death in infancy. Some patients who carry at
least one AGK splice site variant or a start codon muta-
tion develop a milder form of Sengers syndrome and
have a markedly better prognosis. These patients usually
develop cardiomyopathy in later stages. They can survive
even through their 5th decade of life and in the extreme
case, they may only develop cataract.
Currently, no treatment is available for this fatal con-
dition; therefore it is important to identify carriers in at-
risk families in order to provide genetic counseling and
prenatal diagnosis.
In summary, we have identified six novel AGK muta-
tions causing Sengers syndrome. Our findings, along with
the other studies, indicate clinical heterogeneity in pa-
tients harboring AGK mutations. However, interestingly,
congenital or early-onset cataract is the common pheno-
typic finding in all patients, suggesting a role for AGK in
the homeostasis of the human eye lens. We also suggest
that infants with cataract, even in the absence of cardio-
myopathy, should be screened for Sengers syndrome or
AGK mutations. This study verifies the causative role ofAGK in Sengers syndrome and expands the genotype-
phenotype correlations of mutations in this gene. Our re-
sults have important applications in genetic counseling
and prenatal diagnosis.
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